224
Participants
Start Date
February 15, 2017
Primary Completion Date
January 8, 2021
Study Completion Date
March 30, 2023
YH25448
"* Dose Escalation: YH25448 20mg\~320mg, PO~* Dose Expansion: YH25448 40mg\~240mg, PO~* Dose Extension: Recommended Dose 240mg of YH25448"
CHA Bundang Medical Center, CHA University, Seongnam-si
Seoul National University Bundang Hospital, Seongnam-si
The Catholic University of Korea, Bucheon St. Mary's Hospital, Bucheon-si
The Catholic University of Korea, St. Vincent's Hospital, Suwon
Gachon University Gil Medical Center, Incheon
Chungbuk National University Hospital, Cheongju-si
Ulsan University Hospital, Ulsan
Inje University Haeundae Paik Hospital, Busan
Gyeongsang National University Hospital, Jinju
National Cancer Center, Goyang-si
Seoul National University Hospital, Seoul
Kangbuk Samsung Hospital, Seoul
Asan Medical Center, Seoul
Samsung Medical Center, Seoul
SMG-SNU Boramae Medical Center, Seoul
Severance Hospital, Seoul
Yuhan Corporation
INDUSTRY